文献速递心力衰竭与心肌病心律失常

遗传性心肌病致病DNA变异与心血管疾病结局及全因死亡的相关性

Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality.
PubMed 文献 · JAMA Cardiol · 2022-01-01

本研究基于ARIC和UK Biobank队列,评估遗传性心肌病致病或可能致病变异在当代临床实践中的患病率及临床重要性。ARIC中0.61%、UK Biobank中0.73%的参与者携带可干预的致病或可能致病变异,携带者难以通过影像学识别。这些变异与心力衰竭、心房颤动及全因死亡风险增加相关,提示基因检测有助于风险分层。

要点

  • ARIC中0.61%、UK Biobank中0.73%的参与者携带心肌病致病或可能致病变异。
  • 携带者难以通过影像学可靠识别,但心衰、房颤及全因死亡风险增加。
  • 基因检测或可识别临床实践中易漏诊的高危人群。

核心结论

  • 约0.7%的研究参与者携带遗传性心肌病致病或可能致病变异,这些变异与心血管疾病及全因死亡风险增加相关。

研究设计与样本

  • 对13个心肌病相关基因的外显子测序变异,由盲法临床遗传学家按美国医学遗传学与基因组学学会(ACMG)指南进行致病性分类。
  • 主要结局为全因死亡、心力衰竭和心房颤动的发生率。

主要发现

  • ARIC中59名(0.61%)和UK Biobank中364名(0.73%)参与者携带与扩张型或肥厚型心肌病相关的可干预致病或可能致病变异。
  • 在ARIC中,携带者心力衰竭风险增加(HR 1.7;95% CI 1.1-2.8),心房颤动风险增加(HR 2.9;95% CI 1.9-4.5),全因死亡风险增加(HR 1.5;95% CI 1.1-2.2)。
  • UK Biobank中观察到相似的风险模式。
  • 携带者无法通过影像学可靠识别。

临床怎么用

  • 在临床实践中,仅凭影像学难以识别心肌病致病变异携带者,应考虑基因检测以识别高危个体。
  • 识别出的携带者可能需加强心血管风险监测与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Pathogenic variants associated with inherited cardiomyopathy are recognized as important and clinically actionable when identified, leading some clinicians to recommend population-wide genomic screening. OBJECTIVE: To determine the prevalence and clinical importance of pathogenic variants associated with inherited cardiomyopathy within the context of contemporary clinical care. DESIGN, SETTING, AND PARTICIPANTS: This was a genetic association study of participants in Atherosclerosis in Risk Communities (ARIC), recruited from 1987 to 1989, with median follow-up of 27 years, and the UK Biobank, recruited from 2006 to 2010, with median follow-up of 10 years. ARIC participants were recruited from 4 sites across the US. UK Biobank participants were recruited from 22 sites across the UK. Participants in the US were of African and European ancestry; those in the UK were of African, East Asian, South Asian, and European ancestry. Statistical analyses were performed between August 1, 2021, and February 9, 2022. EXPOSURES: Rare genetic variants predisposing to inherited cardiomyopathy. MAIN OUTCOMES AND MEASURES: Pathogenicity of observed DNA sequence variants in sequenced exomes of 13 genes (ACTC1, FLNC, GLA, LMNA, MYBPC3, MYH7, MYL2, MYL3, PRKAG2, TNNI3, TNNT2, TPM1, and TTN) associated with inherited cardiomyopathies were classified by a blinded clinical geneticist per American College of Medical Genetics recommendations. Incidence of all-cause mortality, heart failure, and atrial fibrillation were determined. Cardiac magnetic resonance imaging, echocardiography, and electrocardiogram measures were assessed in a subset of participants. RESULTS: A total of 9667 ARIC participants (mean [SD] age, 54.0 [5.7] years; 4232 women [43.8%]; 2658 African [27.5%] and 7009 European [72.5%] ancestry) and 49 744 UK Biobank participants (mean [SD] age, 57.1 [8.0] years; 27 142 women [54.5%]; 1006 African [2.0%], 173 East Asian [0.3%], 939 South Asian [1.9%], and 46 449 European [93.4%] European ancestry) were included in the study. Of those, 59 participants (0.61%) in ARIC and 364 participants (0.73%) in UK Biobank harbored an actionable pathogenic or likely pathogenic variant associated with dilated or hypertrophic cardiomyopathy. Carriers of these variants were not reliably identifiable by imaging. However, the presence of these variants was associated with increased risk of heart failure (hazard ratio [HR], 1.7; 95% CI, 1.1-2.8), atrial fibrillation (HR, 2.9; 95% CI, 1.9-4.5), and all-cause mortality (HR, 1.5; 95% CI, 1.1-2.2) in ARIC. Similar risk patterns were observed in the UK Biobank. CONCLUSIONS AND RELEVANCE: Results of this genetic association study suggest that approximately 0.7% of study participants harbored a pathogenic variant associated with inherited cardiomyopathy. These variant carriers would be challenging to identify within clinical practice without genetic testing but are at increased risk for cardiovascular disease and all-cause mortality.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Patel AP, Dron JS, Wang M, et al. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality. JAMA Cardiol. 2022. PMID: 35544052. doi:10.1001/jamacardio.2022.0901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。